Sjögren's syndrome
Lisa Christopher-Stine, MD, MPH
Johns Hopkins University
Baltimore, MD, United States
Disclosure(s): Roivant/Priovant: Advisor or Review Panel Member (Ongoing)
Dr. Blake M. Warner, PhD, MPH, DDS
National Institutes of Health
Bethesda, MD, United States
Disclosure(s): Astellas Bio: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Ongoing)
Sjögren's syndrome is typically associated with a lymphocytic and plasmacytic infiltrate in the salivary, parotid, and lacrimal glands, leading to a sicca syndrome, which is commonly encountered in the rheumatology practice. This immune process often affects non-exocrine organs, including the lung and kidneys. The complication of lymphoma is common in Sjögren's and under-recognized.
In this session, we will discuss recognition, prevention, and management of oral complications, ILD, renal disease, and lymphoma.
Virtual Speaker: Alen Zabotti, MD – Azienda Sanitaria Universitaria del Friuli Centrale
Speaker: Sara McCoy, MD, PhD, RhMSUS – University of Wisconsin
Speaker: Leslie P. Laing Gibbard, PhD, BSc, MSc, DDS – Faculty of Dentistry University of Toronto; Sjogren's Society of Canada; Toronto Public Health Dental and Oral Care Clinics
